Annual Current Liabilities
$206.00 K
+$19.00 K+10.16%
31 December 2023
Summary:
XTL Biopharmaceuticals annual total current liabilities is currently $206.00 thousand, with the most recent change of +$19.00 thousand (+10.16%) on 31 December 2023. During the last 3 years, it has fallen by -$48.00 thousand (-18.90%). XTLB annual current liabilities is now -96.16% below its all-time high of $5.37 million, reached on 31 December 2007.XTLB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$223.00 K
+$17.00 K+8.25%
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly total current liabilities is currently $223.00 thousand, with the most recent change of +$17.00 thousand (+8.25%) on 31 March 2024. Over the past year, it has increased by +$61.00 thousand (+37.65%). XTLB quarterly current liabilities is now -96.56% below its all-time high of $6.49 million, reached on 30 June 2008.XTLB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.2% | +37.6% |
| 3 y3 years | -18.9% | +20.5% |
| 5 y5 years | -18.6% | +11.5% |
XTLB Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.9% | +10.2% | -14.2% | +45.8% |
| 5 y | 5 years | -18.9% | +10.2% | -14.2% | +45.8% |
| alltime | all time | -96.2% | +10.2% | -96.6% | +45.8% |
XTL Biopharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $223.00 K(+8.3%) |
| Dec 2023 | $206.00 K(+10.2%) | $206.00 K(+27.2%) |
| Sept 2023 | - | $162.00 K(-0.6%) |
| June 2023 | - | $163.00 K(-32.4%) |
| Mar 2023 | - | $241.00 K(+28.9%) |
| Dec 2022 | $187.00 K(-19.0%) | $187.00 K(+22.2%) |
| Sept 2022 | - | $153.00 K(-11.0%) |
| June 2022 | - | $172.00 K(-33.8%) |
| Mar 2022 | - | $260.00 K(+12.6%) |
| Dec 2021 | $231.00 K(-9.1%) | $231.00 K(+24.9%) |
| Sept 2021 | - | $185.00 K(-28.3%) |
| June 2021 | - | $258.00 K(+2.8%) |
| Mar 2021 | - | $251.00 K(-1.2%) |
| Dec 2020 | $254.00 K(+9.5%) | $254.00 K(+39.6%) |
| Sept 2020 | - | $182.00 K(-6.2%) |
| June 2020 | - | $194.00 K(-20.5%) |
| Mar 2020 | - | $244.00 K(+5.2%) |
| Dec 2019 | $232.00 K(-8.3%) | $232.00 K(+16.0%) |
| Sept 2019 | - | $200.00 K(-1.5%) |
| June 2019 | - | $203.00 K(-14.0%) |
| Mar 2019 | - | $236.00 K(-6.7%) |
| Dec 2018 | $253.00 K(-15.7%) | $253.00 K(+28.4%) |
| Sept 2018 | - | $197.00 K(-0.5%) |
| June 2018 | - | $198.00 K(-14.7%) |
| Mar 2018 | - | $232.00 K(-22.7%) |
| Dec 2017 | $300.00 K(-9.1%) | $300.00 K(+4.9%) |
| Sept 2017 | - | $286.00 K(-25.1%) |
| June 2017 | - | $382.00 K(-29.8%) |
| Mar 2017 | - | $544.00 K(+64.8%) |
| Dec 2016 | $330.00 K(-24.3%) | $330.00 K(+27.9%) |
| June 2016 | - | $258.00 K(-40.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $436.00 K(-54.8%) | $436.00 K(+66.4%) |
| Sept 2015 | - | $262.00 K(+13.4%) |
| June 2015 | - | $231.00 K(-76.1%) |
| Dec 2014 | $965.00 K(-20.8%) | $965.00 K(-18.5%) |
| Sept 2014 | - | $1.18 M(-12.2%) |
| June 2014 | - | $1.35 M(+3.3%) |
| Mar 2014 | - | $1.30 M(+7.1%) |
| Dec 2013 | $1.22 M(-26.1%) | $1.22 M(-5.4%) |
| Sept 2013 | - | $1.29 M(-5.8%) |
| June 2013 | - | $1.37 M(-13.4%) |
| Mar 2013 | - | $1.58 M(-4.1%) |
| Dec 2012 | $1.65 M(-69.3%) | $1.65 M(+123.4%) |
| Sept 2012 | - | $738.00 K(-11.3%) |
| June 2012 | - | $832.00 K(-16.9%) |
| Mar 2012 | - | $1.00 M(+55.7%) |
| Sept 2011 | - | $643.00 K(-7.9%) |
| June 2011 | - | $698.00 K(-15.4%) |
| Mar 2011 | - | $825.00 K(-7.0%) |
| Sept 2010 | - | $887.00 K(+0.6%) |
| June 2010 | - | $882.00 K(+20.3%) |
| Mar 2010 | - | $733.00 K(+15.8%) |
| Sept 2009 | - | $633.00 K(-90.2%) |
| June 2008 | - | $6.49 M(+20.8%) |
| Dec 2007 | $5.37 M(+57.8%) | $5.37 M(+31.1%) |
| June 2007 | - | $4.09 M(+20.3%) |
| Dec 2006 | $3.40 M(+41.4%) | $3.40 M(+9.6%) |
| June 2006 | - | $3.10 M(+29.0%) |
| Dec 2005 | $2.41 M(-31.9%) | $2.41 M(-21.9%) |
| June 2005 | - | $3.08 M(-12.9%) |
| Dec 2004 | $3.53 M(+17.7%) | $3.53 M(-9.5%) |
| June 2004 | - | $3.90 M |
| Dec 2003 | $3.00 M | - |
FAQ
- What is XTL Biopharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual current liabilities year-on-year change?
- What is XTL Biopharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly current liabilities year-on-year change?
What is XTL Biopharmaceuticals annual total current liabilities?
The current annual current liabilities of XTLB is $206.00 K
What is the all time high annual current liabilities for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual total current liabilities is $5.37 M
What is XTL Biopharmaceuticals annual current liabilities year-on-year change?
Over the past year, XTLB annual total current liabilities has changed by +$19.00 K (+10.16%)
What is XTL Biopharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of XTLB is $223.00 K
What is the all time high quarterly current liabilities for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly total current liabilities is $6.49 M
What is XTL Biopharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, XTLB quarterly total current liabilities has changed by +$61.00 K (+37.65%)